Impact of COVID-19 on the treatment of metastatic kidney cancer
Because so little was known about coronavirus at the start [...]
Long term follow-up of immune-related adverse events in cancer survivors
In this study carried out at a single hospital 217 [...]
COVID-19 testing needed for kidney cancer patients
This article from Oncology Nursing News reports the results of [...]
Inflammatory biomarkers for non-metastatic kidney cancer
This study looked at inflammatory biomarkers in the blood for [...]
Comparison of first-line immunotherapy combinations for metastatic kidney cancer
This meta-analysis of first-line immunotherapy trials was published in the [...]
Atexolizumab plus bevacizumab for sarcomatoid kidney cancer
A study published in European Urology in July looks at [...]
Telemedicine appointments during COVID-19
A recent study published in European Urology by the European [...]
Summary from ASCO 2020 virtual meeting
This article nicely summarises the most exciting research highlights from [...]
Re-treatment with immune checkpoint inhibitors in kidney cancer patients
Immune checkpoint inhibitor combinations for the treatment of patients with [...]
Impact of delay in surgery or time to surgery on kidney cancer outcomes
A recent study published in the Journal of Urology this [...]
